# Industry-Specific Benchmarks

## SaaS Benchmarks

### Revenue Metrics
- **ARR**: $1M (seed), $5M (Series A), $20M (Series B)
- **Growth Rate**: >100% (early), >50% (growth), >25% (mature)
- **Gross Margin**: >75% (target), 60-75% (acceptable), <60% (concern)

### Unit Economics
- **LTV/CAC**: >5x (excellent), 3-5x (good), <3x (poor)
- **CAC Payback**: <12 months (excellent), 12-18 months (good), >18 months (concern)
- **Net Revenue Retention**: >120% (excellent), 100-120% (good), <100% (churn issue)

### Efficiency
- **Magic Number**: >1.0 (efficient), 0.75-1.0 (moderate), <0.75 (inefficient)
- **Rule of 40**: >40% (excellent), 20-40% (healthy), <20% (concern)

## E-Commerce Benchmarks

### GMV & Revenue
- **GMV Growth**: >50% (excellent), 25-50% (good), <25% (slow)
- **Take Rate**: >15% (excellent), 10-15% (good), <10% (thin)
- **Gross Margin**: >30% (excellent), 20-30% (acceptable), <20% (concern)

### Customer Metrics
- **Repeat Purchase Rate**: >40% (excellent), 25-40% (good), <25% (concern)
- **AOV Growth**: >20% YoY (excellent), 10-20% (good), <10% (flat)

## B2B Software Benchmarks

### Enterprise Metrics
- **ACV**: >$50K (enterprise), $10-50K (mid-market), <$10K (SMB)
- **Sales Cycle**: <90 days (efficient), 90-180 days (typical), >180 days (complex)
- **Win Rate**: >30% (excellent), 20-30% (good), <20% (concern)

### Customer Success
- **Net Retention**: >110% (excellent), 95-110% (good), <95% (churn)
- **Expansion Revenue**: >30% (excellent), 15-30% (good), <15% (low)

## Fintech Benchmarks

### Transaction Metrics
- **Transaction Volume**: $100M+ (scale), $10-100M (growth), <$10M (early)
- **Take Rate**: >2% (excellent), 1-2% (typical), <1% (thin)
- **Customer Acquisition**: <$50 (efficient), $50-200 (moderate), >$200 (expensive)

### Regulatory
- **Compliance**: SOC 2, PCI-DSS required for scale
- **Licensing**: Money transmitter licenses (state-by-state)

## Healthcare Tech Benchmarks

### Provider Metrics
- **Revenue per Provider**: >$10K (excellent), $5-10K (good), <$5K (low)
- **Adoption Rate**: >50% (high), 25-50% (moderate), <25% (low)
- **Clinical Integration**: Deep (excellent), Moderate (good), Shallow (concern)

### Compliance
- **HIPAA**: Required
- **FDA**: If applicable (Class I, II, or III)

## Marketplace Benchmarks

### Liquidity Metrics
- **GMV**: $50M+ (liquidity), $10-50M (building), <$10M (early)
- **Supply/Demand Balance**: 1.5-2.5:1 (healthy), <1.5 or >2.5 (imbalanced)
- **Transaction Success Rate**: >80% (excellent), 60-80% (good), <60% (friction)

### Network Effects
- **Same-side effects**: Present (excellent), Developing (good), Absent (concern)
- **Cross-side effects**: Strong (excellent), Moderate (good), Weak (concern)

---

## Valuation Multiple Benchmarks

### SaaS
- **High Growth (>100%)**: 15-25x ARR
- **Moderate Growth (50-100%)**: 8-15x ARR
- **Mature (<50%)**: 4-8x ARR

### E-Commerce
- **High Growth**: 2-4x GMV or 6-10x Revenue
- **Moderate Growth**: 1-2x GMV or 4-6x Revenue
- **Mature**: 0.5-1x GMV or 2-4x Revenue

### Marketplace
- **High Liquidity**: 3-6x GMV
- **Building Liquidity**: 1.5-3x GMV
- **Early Stage**: 0.5-1.5x GMV

---

**Use these benchmarks to contextualize company performance against industry standards.**